First Time Loading...

Neuroone Medical Technologies Corp
NASDAQ:NMTC

Watchlist Manager
Neuroone Medical Technologies Corp Logo
Neuroone Medical Technologies Corp
NASDAQ:NMTC
Watchlist
Price: 1.205 USD 3.88% Market Closed
Updated: Mar 28, 2024

Intrinsic Value

NMTC's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

NeuroOne Medical Technologies Corp. operates as a medical technology company. [ Read More ]

The intrinsic value of one NMTC stock under the Base Case scenario is 0.213 USD. Compared to the current market price of 1.205 USD, Neuroone Medical Technologies Corp is Overvalued by 82%.

Key Points:
NMTC Intrinsic Value
Base Case
0.213 USD
Overvaluation 82%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Neuroone Medical Technologies Corp

Backtest NMTC Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling NMTC stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Company Progresses With New FDA Clearance
2024-Q1 Earnings Call

Company Progresses With New FDA Clearance

The company received FDA clearance for its OneRF Ablation System and eyes a limited Q2 2024 launch, potentially via strategic partnerships or direct sales. Expansion in sales and successful Zimmer training suggest growth in Evo sEEG electrode revenue. Other initiatives like sEEG drug delivery could add revenue in late 2024, along with promising spinal cord stimulation studies. Q1 saw product revenue rise to $978,000 from $115,000, but no collaboration revenue, unlike last year's $1.455 million, increased net loss to $3.3 million from $1.7 million, with reduced cash reserves yet no debt.

Financials

Balance Sheet Decomposition
Neuroone Medical Technologies Corp

Current Assets 5.1m
Cash & Short-Term Investments 2.7m
Receivables 543.4k
Other Current Assets 1.9m
Non-Current Assets 729.4k
PP&E 645.4k
Intangibles 84k
Current Liabilities 1.4m
Accounts Payable 760k
Accrued Liabilities 623.2k
Non-Current Liabilities 21k
Other Non-Current Liabilities 21k
Efficiency

Earnings Waterfall
Neuroone Medical Technologies Corp

Revenue
2.9m USD
Cost of Revenue
-2.1m USD
Gross Profit
770.7k USD
Operating Expenses
-14.3m USD
Operating Income
-13.6m USD
Other Expenses
95.2k USD
Net Income
-13.5m USD

Free Cash Flow Analysis
Neuroone Medical Technologies Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

NMTC Profitability Score
Profitability Due Diligence

Neuroone Medical Technologies Corp's profitability score is 16/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Negative 1-Year Revenue Growth
Declining ROE
16/100
Profitability
Score

Neuroone Medical Technologies Corp's profitability score is 16/100. The higher the profitability score, the more profitable the company is.

NMTC Solvency Score
Solvency Due Diligence

Neuroone Medical Technologies Corp's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Low Altman Z-Score
60/100
Solvency
Score

Neuroone Medical Technologies Corp's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NMTC Price Targets Summary
Neuroone Medical Technologies Corp

Wall Street analysts forecast NMTC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NMTC is 3.213 USD with a low forecast of 3.182 USD and a high forecast of 3.308 USD.

Lowest
Price Target
3.182 USD
164% Upside
Average
Price Target
3.213 USD
167% Upside
Highest
Price Target
3.308 USD
174% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

NMTC Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

NMTC Price
Neuroone Medical Technologies Corp

1M 1M
+7%
6M 6M
+37%
1Y 1Y
-21%
3Y 3Y
-84%
5Y 5Y
-90%
10Y 10Y
-90%
Annual Price Range
1.205
52w Low
0.85
52w High
1.99
Price Metrics
Average Annual Return -40.22%
Standard Deviation of Annual Returns 14.31%
Max Drawdown -96%
Shares Statistics
Market Capitalization 29.9m USD
Shares Outstanding 25 930 900
Percentage of Shares Shorted 0.58%

NMTC Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Neuroone Medical Technologies Corp Logo
Neuroone Medical Technologies Corp

Country

United States of America

Industry

Health Care

Market Cap

29.9m USD

Dividend Yield

0%

Description

NeuroOne Medical Technologies Corp. operates as a medical technology company. The company is headquartered in Eden Prairie, Minnesota and currently employs 11 full-time employees. The company went IPO on 2012-11-09. The firm is focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. The company also investigating the applications of its technology associated with artificial intelligence. The company develops its cortical, sheet and depth electrode technology to provides solutions for diagnosis through cEEG recording and sEEG recording and treatment through brain stimulation and ablation. Its commercialized product, Evo sEEG electrode technology records, monitors and stimulates electrical signals at the subsurface level of the brain.

Contact

MINNESOTA
Eden Prairie
7599 Anagram Dr
+19524261383.0
https://www.n1mtc.com

IPO

2012-11-09

Employees

11

Officers

President, CEO & Director
Mr. David A. Rosa M.D.
Chief Financial Officer
Mr. Ronald W. McClurg
Chief Technology Officer
Mr. Steven Mertens
Co-Founder, Business Development Director & Medical Sales Liaison
Mr. Mark Christianson
Chief Operating Officer
Mr. Christopher R. Volker CFA
Vice President of Marketing
Mr. Hijaz Haris

See Also

Discover More
What is the Intrinsic Value of one NMTC stock?

The intrinsic value of one NMTC stock under the Base Case scenario is 0.213 USD.

Is NMTC stock undervalued or overvalued?

Compared to the current market price of 1.205 USD, Neuroone Medical Technologies Corp is Overvalued by 82%.